| Cas No.: | 338992-53-3 |
| Chemical Name: | 4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-, 2,2,2-trifluoroacetate (1:1) |
| Synonyms: | ZD6474 trifluoroacetate;ZD-6474 trifluoroacetate;ZD 6474 trifluoroacetate |
| SMILES: | OC(C(F)(F)F)=O.CN1CCC(COC2C=C3N=CN=C(NC4C=CC(Br)=CC=4F)C3=CC=2OC)CC1 |
| Formula: | C24H25BrF4N4O4 |
| M.Wt: | 589.3773 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | A potent and selective VEGFR2 (KDR) inhibitor with IC50 of 40 nM; shows weak inhibition for VEGFR3 and EGFR (IC50 is 100 nM and 500 nM respectively); displays excellent selectivity over erbB2, MEK, CDK-2, Tie-2, IGFR-1R, PDK, PDGFRβ, and Akt (IC50=1.1-100 uM); has excellent solubility and good oral bioavailability.Thyroid CancerApproved |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
